biotech

#Biotech – Cellectis : preuve de concept dans la leucémie – SmallCapsConfidentiel http://t.co/tohzjjAHEn via @ghabault jallatte (@jallatte) July 05, 2013 Cellectis (FR0010425595) a annoncé hier, jeudi 4 juillet, une seconde avancée technique dans son...

Un groupe de #biotech dit avoir découvert un traitement contre la leucémie http://t.co/0BuTeGpxS7 cc @ghabault jallatte (@jallatte) July 05, 2013 Des cellules atteintes par la leucémie. (STEVE GSCHMEISSNER / AFP) Si c'est confirmé, il s'agit d'une étape...

#Biotech La génomique sort des laboratoires | Santé http://t.co/LLTBrPXRkQ cc @ghabault jallatte (@jallatte) July 05, 2013 Le ministre d'État aux Sciences et à la Technologie, Gary Goodyear, et le président de Génome Canada, Pierre Meulien, annonceront...

#Pharma #Bourse Imperial Innovations pulls in £30 million from EIB to invest in #biotech http://t.co/7C8gAruGnv cc @ghabault jallatte (@jallatte) July 05, 2013 AIM-listed investment firm Imperial Innovations Group has secured a £30 million loan so that...

#Santé #Recherche #Biotech Single shot of Biogen's haemophilia drug controls 87% of bleeds http://t.co/g1a2CgnQzA (bis) @ghabault jallatte (@jallatte) July 05, 2013 Biogen Idec and Swedish Orphan Biovitrum (Sobi) have unveiled late-stage clinical data...

#Biotech #UK Jeremy Hunt launches genomics body to oversee healthcare revolution http://t.co/qbwYJtl9Y9 Et nous? @GHABAULT @ALarigaudrieBFM jallatte (@jallatte) July 05, 2013 The health secretary is launching a new government organisation to oversee the...

#Recherche #Biotech Biogen, Sobi share phase 3 results of haemophilia A drug - http://t.co/Y7jJztqLbU jallatte (@jallatte) July 05, 2013 Biogen, Sobi share phase 3 results of haemophilia A drug - News Biogen and the rare disease pharma company, Swedish...

#Biotech #Cancer Drug firm hires 25 as it seals huge development deal http://t.co/CQn9xC5xdy ça bouge pas qu'en bourse jallatte (@jallatte) July 05, 2013 A THRIVING biotech firm is recruiting 25 new staff this year after landing one of the biggest financial...

#Pharma #Bourse #Biotech Cardio3 prices IPO at 16.65 euros per share | Reuters http://t.co/z9jE9LaML4 rappel @ghabault jallatte (@jallatte) July 05, 2013 BRUSSELS, July 4 (Reuters) - Belgian heart drug specialistCardio3 BioSciences prices its initial...

#Biotech Genentech FDA Accepts Obinutuzumab BLA http://t.co/e53H5Z5MFs jallatte (@jallatte) July 04, 2013 Genentech announced that the U.S. Food and Drug Administration has accepted its Biologics License Application for obinutuzumab and granted Priority...